Personalis, Inc.

US$15.79As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PSNLHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (7.10%)
Div yield —
ROE (62.14%)
Diagnostics & Research
Beta (5Y) 2.36
PE TTM —
TSR TTM 63.80%
Mkt cap US$1.712B
ROIC (33.92%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$19
19.30%
(81.63%)
Hold 3|11|5|10|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.26
0.29
0.32
0.34
6.84%
15.24%
18.89%
25.98%
Revenue$M
107.5
113.0
116.3
113.8
7.76%
12.43%
10.38%
7.43%
Peers (US$1.712B)
Cap (US$)
PE
2.179B
—
1.950B
15.78x
Capital
TTM
5Y
10Y
Leveragex
0.637
—
—
EBIT/Intx
6.644
0.450
0.393
Own earn%
68.37
88.86
81.72
Sh yield%
46.92
54.41
51.97
Owners
Insiders/Inst%
1.68
76.10
Short interest%
1.75
SBC / revenue%
1.58
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
3–13
$1 testx
−0.2
Incr. ROIC%
87